BIOMAT Database Logo BIOMAT Database Logo

[The effect of bone marrow hexapeptides (myelopeptides) on antibody formation and pain sensitivity in mice and dependence of these effects on naloxone]. 1995

E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ

UI MeSH Term Description Entries
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D005260 Female Females
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
Immunoregulatory effects of two bone-marrow hexapeptides (myelopeptides) in experimental models of immunodeficiency.
September 1995, Immunology letters,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
[Effect of myelopeptides on bone marrow T-lymphocyte precursors].
January 1989, Doklady Akademii nauk SSSR,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
[Effects of high and low molecular soluble factors of the bone marrow on antibody formation and pain sensitivity in animals].
January 1990, Biulleten' eksperimental'noi biologii i meditsiny,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
[Regulatory mediators of the bone marrow--myelopeptides].
January 1985, Vestnik Akademii meditsinskikh nauk SSSR,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
Deficient antibody formation in the bone marrow of nude mice.
October 1978, Immunology,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides).
July 2003, Regulatory peptides,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
Antibody formation in mouse bone marrow. VIII. Dependence on potentially circulating memory cells: a study with parabiotic mice.
October 1977, Cellular immunology,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
Structures of two myelopeptides affecting pain sensitivity.
January 1991, Biomedical science,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
[Structure of two myelopeptides affecting pain sensitivity].
January 1991, Doklady Akademii nauk SSSR,
E E Metaksa, and L A Zakharova, and O V Koptelov, and N A Koroleva, and O G Ianovskiĭ
[Effect of myelopeptides on physiological and pathological pain].
August 1986, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!